Treatment patterns and risk factor control in patients with and without metabolic syndrome in cardiac rehabilitation

References

• GreenlandPAlpertJSBellerGA2010ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol20105625e50e10321144964
   PubMed Web of Science ®Google Scholar
• World Health OrganizationDefinition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO ConsultationPart 1: Diagnosis and classification of diabetes mellitusGeneva1999
   Google Scholar
• KernerWBrückelJBöhmBDefinition, classification and diagnostics of diabetes mellitusGuidelines of the German Diabetes Society [Deutsche Diabetes Gesellschaft DDG]ScherbaumWAKiessW2004German
   Google Scholar
• EinhornDReavenGMCobinRHAmerican College of Endocrinology position statement on the insulin resistance syndromeEndocr Pract20039323725212924350
   PubMedGoogle Scholar
• GrundySMBrewerHBJrCleemanJIDefinition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definitionCirculation2004109343343814744958
   PubMed Web of Science ®Google Scholar
• BloomgardenZTAmerican Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: August 25–26, 2002, Washington, DCDiabetes Care200326393393912610060
   PubMedGoogle Scholar
• Internation Diabetes FederationIDF worldwide definition of the metabolic syndrome Available from: http://www.idf.org/idf-worldwide-definition-metabolic-syndromeAccessed on December 22, 2010
   Google Scholar
• AdesPACardiac rehabilitation and secondary prevention of coronary heart diseaseN Engl J Med20013451289290211565523
   PubMed Web of Science ®Google Scholar
• KaroffMHeldKBjarnason-WehrensBCardiac rehabilitation in GermanyEur J Cardiovasc Prev Rehabil2007141182717301623
   PubMedGoogle Scholar
• HaskellWLAldermanELFairJMEffects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP)Circulation19948939759908124838
   PubMed Web of Science ®Google Scholar
• NiebauerJHambrechtRVelichTAttenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exerciseCirculation1997968253425419355890
   PubMed Web of Science ®Google Scholar
• OrnishDScherwitzLWBillingsJHIntensive lifestyle changes for reversal of coronary heart diseaseJAMA199828023200120079863851
   PubMed Web of Science ®Google Scholar
• O’ConnorGTBuringJEYusufSAn overview of randomized trials of rehabilitation with exercise after myocardial infarctionCirculation19898022342442665973
   PubMed Web of Science ®Google Scholar
• WillichSNMuller-NordhornJKuligMCardiac risk factors, medication, and recurrent clinical events after acute coronary disease; a prospective cohort studyEur Heart J200122430731311161949
   PubMed Web of Science ®Google Scholar
• BestehornKWegscheiderKVollerHContemporary trends in cardiac rehabilitation in Germany: patient characteristics, drug treatment, and risk-factor management from 2000 to 2005Eur J Cardiovasc Prev Rehabil200815331231818525386
   PubMedGoogle Scholar
• German Society for Prevention and Rehabilitation of Cardiovascular Disease [Deutsche Gesellschaft für Prävention und Rehabilitation von Herz-Kreislauferkrankungen e.V., Koblenz, Germany] Available from: http://www.dgpr.deAccessed March 28, 2012German
   Google Scholar
• VöllerHReibisRPittrowDSecondary prevention of diabetic patients with coronary artery disease in cardiac rehabilitation: risk factors, treatment and target level attainmentCurr Med Res Opin200925487989019254205
   PubMed Web of Science ®Google Scholar
• MadalaMCFranklinBAChenAYObesity and age of first non-ST-segment elevation myocardial infarctionJ Am Coll Cardiol2008521297998518786477
   PubMed Web of Science ®Google Scholar
• MilaniRVLavieCJPrevalence and profile of metabolic syndrome in patients following acute coronary events and effects of therapeutic lifestyle change with cardiac rehabilitationAm J Cardiol2003921505412842245
   PubMed Web of Science ®Google Scholar
• MilionisHJKostapanosMSLiberopoulosENDifferent definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjectsInt J Clin Pract200761454555117394429
   PubMed Web of Science ®Google Scholar
• AthyrosVGGanotakisESElisafMMikhailidisDPThe prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitionsCurr Med Res Opin20052181157115916083523
   PubMed Web of Science ®Google Scholar
• KahnRBuseJFerranniniESternMThe metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care20052892289230416123508
   PubMed Web of Science ®Google Scholar
• KahnRMetabolic syndrome – what is the clinical usefulness?Lancet200837196281892189318501420
   PubMed Web of Science ®Google Scholar
• SattarNMcConnachieAShaperAGCan metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studiesLancet200837196281927193518501419
   PubMed Web of Science ®Google Scholar
• GrundySMDoes a diagnosis of metabolic syndrome have value in clinical practice?Am J Clin Nutr20068361248125116762931
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA2001285192486249711368702
   PubMed Web of Science ®Google Scholar
• ChobanianAVBakrisGLBlackHRThe seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 reportJAMA2003289192560257112748199
   PubMed Web of Science ®Google Scholar
• RydenLStandlEBartnikMGuidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)Eur Heart J20072818813617220161
   PubMed Web of Science ®Google Scholar
• BaladyGJAdesPAComossPCore components of cardiac rehabilitation/secondary prevention programs: a statement for healthcare professionals from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation Writing GroupCirculation200010291069107310961975
   PubMed Web of Science ®Google Scholar
• O’HartaighBJiangCQThomasGNUsefulness of physical fitness and the metabolic syndrome to predict vascular disease risk in older Chinese (from the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort [GBCS-CVD])Am J Cardiol2011108684585021784386
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (FDA)FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury Available from: http://www.fda.gov/Drugs/DrugSafety/ucm256581.htmAccessed March 27, 2012
   Google Scholar
• IjiomaNRobinsonJGLipid-lowering effects of ezetimibe and simvastatin in combinationExpert Rev Cardiovasc Ther20119213114521453210
   PubMedGoogle Scholar
• BestehornKJannowitzCKarmannBPittrowDKirchWCharacteristics, management and attainment of lipid target levels in patients enrolled in Disease Management Program versus those in routine care: LUTZ registryBMC Public Health20099128019653899
   PubMed Web of Science ®Google Scholar
• GittAKJuengerCJannowitzCKarmannBSengesJBestehornKGuideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registryEur J Cardiovasc Prev Rehabil200916443844419369876
   PubMedGoogle Scholar
• GittAKJungerCSmolkaWBestehornKPrevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in GermanyClin Res Cardiol2010991172373320521058
   PubMed Web of Science ®Google Scholar
• BöhlerSScharnaglHFreisingerFUnmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in GermanyAtherosclerosis2007190239716546194
   PubMed Web of Science ®Google Scholar
• PittrowDStallaGKZeiherAMPrevalence, drug treatment and metabolic control of diabetes mellitus in primary careMed Klin (Munich)2006101863564416896570
   PubMedGoogle Scholar
• SharmaAWittchenHKirchWHigh prevalence and poor control of hypertension in primary care: cross sectional studyJ Hypertens20042247948615076152
   PubMed Web of Science ®Google Scholar
• PittrowDKirchWBramlagePPatterns of antihypertensive drug utilization in primary careEur J Clin Pharmacol200460213514215042351
   PubMed Web of Science ®Google Scholar
• MaglianoDJShawJEZimmetPZHow to best define the metabolic syndromeAnn Med2006381344116448987
   PubMed Web of Science ®Google Scholar